Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder
Authors
Ryan Zurick
Ryan E. Tyler (ORCID: https://orcid.org/0000-0002-4495-037X)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of General Medical Sciences
National Center for Advancing Translational Sciences
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder
Ryan Zurick, Ryan E. Tyler, Oluwatobi Arisa, Yi Arial Zeng et al.
Journal
The International Journal of Neuropsychopharmacology
Topics
Regulation of Appetite and Obesity
article
Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder
Ryan Zurick, Ryan E. Tyler, Oluwatobi Arisa, Yi Arial Zeng, Lorenzo Leggio, Mehdi Farokhnia, Anna Loften, Rabea K Pfaff, R M Naseer Khan, William D Figg, Fatemeh Akhlaghi, Charlotte Harvey
article en
Abstract
No abstract available for this paper.
Publication Tag
The International Journal of NeuropsychopharmacologyVol. 29(2)
Institutions
National Institute on Drug Abuse (US), BD Biosciences (United States) (US), National Institute on Alcohol Abuse and Alcoholism (US), National Cancer Institute (US), National Institutes of Health Clinical Center (US)
Funders
Svenska Läkaresällskapet, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences